Should the Window for Intravenous Administration of Tissue Plasminogen Activator in the Treatment of Acute Ischemic Stroke Be Extended to 4.5 Hours?
Canadian Journal of Hospital Pharmacy - Canada
doi 10.4212/cjhp.v62i3.798
Full Text
Open PDFAbstract
Available in full text
Date
June 3, 2009
Authors
Publisher
Canadian Society of Hospital Pharmacists (CSHP)